SRC and epilepsy: We found that patients with symptomatic epilepsy showed a remarkable increase in protein levels of NRG1 and ErbB4 in the temporal cortex and a substantial decrease in the phosphorylation levels of Glu2B-pY1472 and Src-pY416, two downstream targets of NRG1-ErbB4 signaling.